Chemoinformaics analysis of 1-O-Sinapoyl-beta-D-glucose
| Molecular Weight | 386.353 | nRot | 6 |
| Heavy Atom Molecular Weight | 364.177 | nRig | 14 |
| Exact Molecular Weight | 386.121 | nRing | 2 |
| Solubility: LogS | -1.245 | nHRing | 1 |
| Solubility: LogP | -0.424 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 6 |
| nHA | 10 | APOL | 51.0794 |
| nHD | 5 | BPOL | 29.8826 |
| QED | 0.296 |
| Synth | 3.68 |
| Natural Product Likeliness | 1.796 |
| NR-PPAR-gamma | 0.822 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.916 |
| HIA | 0.932 |
| CACO-2 | -6.169 |
| MDCK | 0.000150286 |
| BBB | 0.719 |
| PPB | 0.48659 |
| VDSS | 0.435 |
| FU | 0.252767 |
| CYP1A2-inh | 0.021 |
| CYP1A2-sub | 0.1 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.669 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.476 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.278 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.036 |
| CL | 3.639 |
| T12 | 0.885 |
| hERG | 0.028 |
| Ames | 0.238 |
| ROA | 0.106 |
| SkinSen | 0.245 |
| Carcinogencity | 0.107 |
| EI | 0.009 |
| Respiratory | 0.037 |
| NR-Aromatase | 0.649 |
| Antiviral | No |
| Prediction | 0.579246 |